IRVINE, Calif., July 9, 2020 /PRNewswire/ -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in patient-focused
innovations for structural heart disease and critical care
monitoring, plans to announce its operating results for the quarter
ended June 30, 2020 after the market
closes on Thursday, July 23, 2020,
and will host a conference call at 5:00 p.m.
ET that day to discuss those results.
To participate in the conference call, dial (877) 704-2848 or
(201) 389-0893. For 72 hours following the call, an audio
replay can be accessed by dialing (877) 660-6853 or (201) 612-7415
and using conference number 13705594. The call will also be
available via live or archived webcast on the "Investor Relations"
section of the Edwards web site at ir.edwards.com.
About Edwards Lifesciences
Edwards Lifesciences, based in Irvine,
Calif., is the global leader of patient-focused medical
innovations for structural heart disease and critical care
monitoring. We are driven by a passion for patients,
dedicated to improving and enhancing lives through partnerships
with clinicians and stakeholders across the global healthcare
landscape. For more information, visit Edwards.com and follow
us on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation. All other
trademarks are the property of their respective owners.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-host-earnings-conference-call-on-july-23-2020-301090739.html
SOURCE Edwards Lifesciences Corporation